Ministerul Sanatatii a stabilit inceperea imunizarii gratuite impotriva gripei de sezon pentru data de 15 Octombrie. Aceasta vaccinare va avea loc inaintea celei impotriva virusului A/H1N1 si va viza reducerea la maximum a imbolnavirilor prin gripa de sezon. Teoretic, vaccinarea va fi recomandata tuturor celor care au implinit peste 6 luni. Au fost alocate 3,7 milioane doze de vaccin pentru acest an.

Despre eficienta imunizarii am gasit un video mai mult decat relevant:

In plus, Ministerul Sanatatii a anuntat ca in Decembrie incepe si campania de vaccinare impotriva gripei A/H1N1.

De AICI am preluat cateva prevederi legale pentru distributia catre statele UE.

Avem:

Regulatory process for the authorisation of antiviral medicines and vaccines in the protection against Pandemic Influenza (H1N1) 2009.
Accompanying document to the
COMMUNICATION FROM THE COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT AND THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

Ce ne intereseaza pe noi este Articolul 3.5, din care aflam:

As a general rule, marketing authorisation holders are subject to liability for the use of their products as long as they are used within the terms of the marketing authorisation.

Member States may temporarily authorise the distribution of an unauthorised medicinal product in response to the suspected or confirmed spread of pathogenic agents. This encompasses pandemic situations, such as the Influenza A (H1N1) 2009 pandemic. In such a case marketing authorisation holders, manufacturers and health professionals are not subject to civil or administrative liability for any consequences resulting from the use of a vaccine when such use of an unauthorised vaccine is recommended or required by a competent authority in response to the pandemic situation. This also applies when the use of an authorised medicinal product, such as an antiviral medicine and a vaccine, is recommended beyond authorised conditions (e.g. indications, age groups). These provisions apply independently whether a national or Community authorisation has been granted.

In traducere:

Ca regula generala, detinatorii autorizatiilor de comercializare sunt responsabili pentru folosirea produselor lor, atata timp cat sunt folosite in termenii autorizatiei de punere pe piata.

Statele membre pot autoriza temporar distribuirea unui produs medical neautorizat, ca raspuns la raspandirea -- suspectata sau confirmata -- a agentilor patogeni. Aceasta prevedere acopera situatiile pandemice, cum este Virusul A (H1N1) 2009. In acest caz, detinatorii autorizatiei de comercializare si larga distributie, producatorii si angajatii din domeniul sanitar nu pot fi considerati responsabili civil sau administrativ pentru nicio consecinta rezultata din folosirea unui vaccin, cand folosirea unui vaccin neautorizat a fost recomandata sau impusa de o autoritate competenta, ca raspuns la situatia pandemica. Aceasta prevedere se aplica si in cazul folosirii unui produs medical autorizat, cum ar fi medicatia antivirala si vaccinarea, atunci cand acestea sunt recomandate si in afara conditiilor autorizate (cum ar fi indicatiile sau grupele de varsta). Aceste prevederi se aplica independent, indiferent daca o autorizare nationala sau Comunitara a fost garantata.   —

Doua personalitati medicale cu opinii in domeniu:
1) Dr. James Howenstine (il citeaza si pe James R. Shannon, fost director al NIH -- National Institute of Health)
Why You Should Avoid Taking Vaccines

2) Russell L. Blaylock, neurochirurg
The Truth Behind the Vaccine Coverup

In order to understand the current status of medical care in the U.S., Canada and Europe it is vital to understand that health care in these 3 regions is nearly completely under the control of the pharmaceutical industry. All major pharmaceutical firms have interlocking boards of directors so there is no real competition among these companies.”

Publicat in data de 09.10.09, in sectiunea TEXTE |

Comenteaza